Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2021-10-01 Acc 0001209191-21-058521

Director bought 315 shares at an average $2.83 ($891)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Young Caroline Director	2021-09-01	Purchase	+15	$2.88	$43	13,373	D
Young Caroline Director	2021-09-02	Purchase	+15	$2.88	$43	13,388	D
Young Caroline Director	2021-09-03	Purchase	+15	$2.85	$43	13,403	D
Young Caroline Director	2021-09-07	Purchase	+15	$2.79	$42	13,418	D
Young Caroline Director	2021-09-08	Purchase	+15	$2.89	$43	13,433	D
Young Caroline Director	2021-09-09	Purchase	+15	$2.77	$42	13,448	D
Young Caroline Director	2021-09-10	Purchase	+15	$2.78	$42	13,463	D
Young Caroline Director	2021-09-13	Purchase	+15	$2.96	$44	13,478	D
Young Caroline Director	2021-09-14	Purchase	+15	$3.02	$45	13,493	D
Young Caroline Director	2021-09-15	Purchase	+15	$2.86	$43	13,508	D
Young Caroline Director	2021-09-16	Purchase	+15	$2.91	$44	13,523	D
Young Caroline Director	2021-09-17	Purchase	+15	$2.85	$43	13,538	D
Young Caroline Director	2021-09-20	Purchase	+15	$2.82	$42	13,553	D
Young Caroline Director	2021-09-21	Purchase	+15	$2.81	$42	13,568	D
Young Caroline Director	2021-09-22	Purchase	+15	$2.76	$41	13,583	D
Young Caroline Director	2021-09-23	Purchase	+15	$2.75	$41	13,598	D
Young Caroline Director	2021-09-24	Purchase	+15	$2.74	$41	13,613	D
Young Caroline Director	2021-09-27	Purchase	+15	$2.79	$42	13,628	D
Young Caroline Director	2021-09-28	Purchase	+15	$2.76	$41	13,643	D
Young Caroline Director	2021-09-29	Purchase	+15	$2.82	$42	13,658	D
Young Caroline Director	2021-09-30	Purchase	+15	$2.72	$41	13,673	D
Open-market purchases · 315 sh · avg $2.83 · $891